The Gregory Foundation for Cancer Research Funds Phase Ib-II clinical trial for Rhabdomyosarcoma by Partnering with
The Gregory Foundation finds and funds breakthrough therapies for childhood cancers and initiates access to medicine for children affected by cancer in poor countries.
To date, only four drugs have been specifically developed and approved for pediatric cancer, thus forcing oncologists to use in children cancer treatments that were mainly developed for adult cancers.
“We need more innovative treatments that reach the clinic quicker and for this, all efforts are needed. As a non-profit, we not only fund academic research but also to support start-ups with a clear path, solid team and strong connections in pediatric oncology that is committed to quickly bringing new drugs to market specifically designed for children with cancer.”
To date, The Gregory Foundation has provided funds to Oncoheroes Biosciences to develop drugs for pediatric cancers. This support will help accelerate the clinical drug development of volasertib, propelling it into a Phase Ib-II clinical trial for Rhabdomyosarcoma, a very aggressive form of pediatric cancer.
We hope to continue funding research and supporting children affected by cancer in the US and around the world.
You have items in your cart!
Once you leave this campaign, your cart items will not carry over to another campaign.
Complete your cart transaction before moving on if you don't want to lose these cart items.
It looks like you're using an outdated browser, which cannot properly display this page. Please switch to a different browser such as Chrome, Firefox, Safari or Edge. You can download any of these supported browsers using the following links: